UB Paderborn / Katalog / Suche / in CDI

The antibiotic pipeline: reviving research and development and speeding drugs to market

Expert review of anti-infective therapy, 2017-05, Vol.15 (5), p.425-433

2017

Link zum Volltext

Verfügbarkeit prüfen

Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications

Pharmacotherapy, 2017-01, Vol.37 (1), p.71-84

2017

Link zum Volltext

Verfügbarkeit prüfen

Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureus

Clinical infectious diseases, 2007-06, Vol.44 (12), p.1536-1542

2007

Link zum Volltext

Verfügbarkeit prüfen

Update on the Efficacy and Tolerability of Meropenem in the Treatment of Serious Bacterial Infections

Clinical infectious diseases, 2008-09, Vol.47 (Supplement-1), p.S41-S51

Mohr, John F.

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective Survey of (1[rightward arrow]3)-β-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

Journal of Clinical Microbiology, 2011-01, Vol.49 (1), p.58-61

2011

Link zum Volltext

Verfügbarkeit prüfen

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

Frontiers in medicine, 2020-12, Vol.7, p.585658-585658

2020

Link zum Volltext

Verfügbarkeit prüfen

Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus

Journal of Clinical Microbiology, 2011-06, Vol.49 (6), p.2272-2273

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetic Evaluation of Single-Dose Intravenous Daptomycin in Patients with Thermal Burn Injury

Antimicrobial Agents and Chemotherapy, 2008-05, Vol.52 (5), p.1891-1893

2008

Link zum Volltext

Verfügbarkeit prüfen

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion

Structural heart (Online), 2022-08, Vol.6 (4), p.100076-100076, Article 100076

2022

Link zum Volltext

Verfügbarkeit prüfen

Dysglycaemias and Fluoroquinolones

Drug safety, 2008-01, Vol.31 (4), p.283-292

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin

Journal of Clinical Microbiology, 2011-10, Vol.49 (10), p.3669-3672

2011

Link zum Volltext

Verfügbarkeit prüfen

Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycin

Journal of Clinical Microbiology, 2010-03, Vol.48 (3), p.894-899

2010

Link zum Volltext

Verfügbarkeit prüfen

A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

Pharmacotherapy, 2005-10, Vol.25 (10), p.1303-1309

2005

Link zum Volltext

Verfügbarkeit prüfen

Intravenous fosfomycin for the treatment of hospitalized patients with serious infections

Expert review of anti-infective therapy, 2017-10, Vol.15 (10), p.935-945

2017

Link zum Volltext

Verfügbarkeit prüfen

Decreasing the Probability of Creatine Phosphokinase Elevations: Clinical Considerations for Daptomycin Dosing in Obese Patients

Clinical infectious diseases, 2010-10, Vol.51 (8), p.989-989

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

Journal of antimicrobial chemotherapy, 2009-12, Vol.64 (6), p.1130-1138

2009

Link zum Volltext

Verfügbarkeit prüfen

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations

ClinicoEconomics and outcomes research, 2023-09, Vol.15, p.721-731

2023

Link zum Volltext

Verfügbarkeit prüfen

Significant publications on infectious diseases pharmacotherapy in 2010

American journal of health-system pharmacy, 2011-11, Vol.68 (21), p.2075-2085

2011

Link zum Volltext

Verfügbarkeit prüfen

Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US

ClinicoEconomics and outcomes research, 2023-01, Vol.15, p.139-149

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study

Future cardiology, 2023-06, Vol.19 (8), p.385-396

2023

Link zum Volltext

Verfügbarkeit prüfen

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

International journal of antimicrobial agents, 2009-06, Vol.33 (6), p.543-548

2009

Link zum Volltext

Verfügbarkeit prüfen

Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials

Journal of antimicrobial chemotherapy, 2015-04, Vol.70 (4), p.1274-1275

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: A retrospective, nested case-controlled analysis

Clinical therapeutics, 2008, Vol.30 (1), p.152-157

2008

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Susceptibility Testing: A Primer for Clinicians

Pharmacotherapy, 2009-11, Vol.29 (11), p.1326-1343

2009

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Intravenous Itraconazole in Stable Hemodialysis Patients

Antimicrobial Agents and Chemotherapy, 2004-08, Vol.48 (8), p.3151-3153

2004

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The antibiotic pipeline: reviving research and development and speeding drugs to market

Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications

Point: Vancomycin Is Not Obsolete for the Treatment of Infection Caused by Methicillin-Resistant Staphylococcus aureus

Update on the Efficacy and Tolerability of Meropenem in the Treatment of Serious Bacterial Infections

Prospective Survey of (1[rightward arrow]3)-β-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

Outpatient Subcutaneous Antimicrobial Therapy (OSCAT) as a Measure to Improve the Quality and Efficiency of Healthcare Delivery for Patients With Serious Bacterial Infections

Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus

Pharmacokinetic Evaluation of Single-Dose Intravenous Daptomycin in Patients with Thermal Burn Injury

From Oral to Subcutaneous Furosemide: The Road to Novel Opportunities to Manage Congestion

Dysglycaemias and Fluoroquinolones

Predictors of Relapse of Methicillin-Resistant Staphylococcus aureus Bacteremia after Treatment with Vancomycin

Clinical Characteristics, Outcomes, and Microbiologic Features Associated with Methicillin-Resistant Staphylococcus aureus Bacteremia in Pediatric Patients Treated with Vancomycin

A Retrospective, Comparative Evaluation of Dysglycemias in Hospitalized Patients Receiving Gatifloxacin, Levofloxacin, Ciprofloxacin, or Ceftriaxone

Intravenous fosfomycin for the treatment of hospitalized patients with serious infections

Decreasing the Probability of Creatine Phosphokinase Elevations: Clinical Considerations for Daptomycin Dosing in Obese Patients

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

Examining the Burden of Potentially Avoidable Heart Failure Hospitalizations

Significant publications on infectious diseases pharmacotherapy in 2010

Descriptive Epidemiology and Outcomes of Patients with Short Stay Hospitalizations for the Treatment of Congestive Heart Failure in the US

Reduced heart failure-related healthcare costs with Furoscix versus in-hospital intravenous diuresis in heart failure patients: the FREEDOM-HF study

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials

Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: A retrospective, nested case-controlled analysis

Antimicrobial Susceptibility Testing: A Primer for Clinicians

Pharmacokinetics of Intravenous Itraconazole in Stable Hemodialysis Patients

Suchergebnisse filtern